U.S. Hotel and Resort REITs Stock News

Why Butterfly Network Stock Is Back on Investors’ Radar Butterfly Network (BFLY) is drawing fresh attention after raising its 2026 revenue outlook to US$119 million to US$123 million and issuing higher guidance for the third quarter following its latest earnings report. See our latest analysis for Butterfly Network. Butterfly Network’s raised guidance and stronger recent earnings sit alongside sharp share price momentum, with the stock posting a 30 day share price return of 9.5% and a 1 year...

With fresh US tariffs on imported polysilicon and new incentives for domestic production, the quiet world of semiconductor materials has suddenly moved to center stage. This policy shift could reshape where critical inputs for chips and solar panels are sourced, which matters for investors watching supply chains and pricing power. This article walks through 3 US semiconductor materials stocks exposed to this news and how each might fit, or might not fit, in a portfolio. The stocks highlighted...

Alpha Teknova stock rose 16.4% to close at US$6.53, capping a strong week for investors who were already sitting on solid short term gains. The market is focusing on one key development above all else. The headline result is that Q2 delivered the highest quarterly revenue in the company’s history, with more than US$12 million in sales and a clear step down in the quarterly net loss. That combination of record revenue and a narrower loss appears to have driven today’s shift in sentiment. The...

AbCellera Biologics jumped 10.3% to US$6.53 today, a sharp move for a stock that came into the print with a mixed recent run, up over the past week but down over the past month. The market is reacting to one thing above all else: the company is leaning hard into a high cash burn and deeper quarterly loss to fund its antibody pipeline, backed by a reported US$567 million cash pile and more than US$675 million of available liquidity. The question now is whether that liquidity cushion really...

Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against its longer term returns and current fundamentals. See our latest analysis for Novo Nordisk. That jump in Novo Nordisk’s share price over the last session sits against a weaker backdrop, with the 7 day share price return down 10.93% and the year to date share price return down 12.25%. The 1 year total shareholder return is down 2.61%...

Evolus stock just ripped almost 20% higher to US$7.41, and the move is all about one thing. The market is latching onto a margin and profitability turn that feels very different from the company investors watched over the past year. Q2 revenue of US$84.1m, helped by aesthetics demand across toxins and fillers, arrived alongside a third straight quarter of positive adjusted earnings before interest, taxes, depreciation and amortization. That shift in earnings quality is what traders are...

In early August 2026, Toast, Inc. reported Q2 results showing higher revenue and net income than a year earlier, completed a US$648.33 million share repurchase program, and saw its ongoing AI partnership with Google deepen while BWH Hotels endorsed Toast as a POS option across the U.S. and Canada. Together, the stronger profitability, expanding AI-driven integrations, and entry into large hospitality networks highlight Toast’s effort to deepen its ecosystem and broaden its customer reach...

Q2 2026 earnings snapshot Timken (TKR) has reported second quarter 2026 results, providing fresh data on how the business is performing across its bearings and industrial motion operations. For the quarter ended June 30, 2026, sales were US$1,260.9 million compared with US$1,173.4 million a year earlier. Net income was US$28.9 million compared with US$78.5 million in the prior year period. Basic earnings per share from continuing operations were US$0.42 compared with US$1.13 a year ago...

Recent Performance Context For SLM Stock SLM (SLM) has drawn investor interest after a period of mixed returns, with the stock higher over the past week, month and past 3 months, yet lower over the past year. At a recent close of US$27.41 and a market value of about US$5.2b, SLM sits against a backdrop of declining annual revenue and net income growth, which keeps the loan-focused business model in sharper focus for investors. See our latest analysis for SLM. SLM’s share price has gained over...

Conagra Brands (CAG) is back on investor radars after Conagra Brands Canada introduced Marigold, a chef-inspired Indian frozen entrée and cooking sauce line. This signals a fresh product push in the Canadian market. See our latest analysis for Conagra Brands. Despite the Marigold launch and recent leadership changes, Conagra Brands’ share price has had mixed momentum, with a 30 day share price return of 5.84% but a year to date share price decline of 14.16%. Over the longer term, the total...

Axsome Therapeutics stock has delivered a very large 5 year gain, yet the current set of valuation checks and market multiples together suggest the share price no longer looks obviously cheap or clearly overpriced. Axsome Therapeutics has returned roughly 7.6x over 5 years, which puts the recent pullback in the context of a very long running upswing that investors need to judge carefully. Expectations around Axsome Therapeutics turning its pipeline and portfolio into durable cash flow can...

In the second quarter of 2026, Precigen, Inc. reported revenue of US$54.98 million, net income of US$20.07 million, and diluted earnings per share from continuing operations of US$0.05, a sharp turnaround from the prior year’s loss-making period. This profitability was driven largely by rapid uptake of Papsimios, supported by expanded payer coverage to about 315 million US lives and seven-year FDA market exclusivity for adult recurrent respiratory papillomatosis. Next, we will examine how...

Why Universal Health Services Stock Is Back on Investors’ Radar Universal Health Services (UHS) has drawn fresh attention after reporting second quarter 2026 results and confirming completion of a long running share repurchase program that has been in place since July 2014. Both events give investors new information on recent operating performance and capital allocation choices as of late July 2026. Together they frame how you might think about the stock today. See our latest analysis for...

IQVIA Holdings (IQV) stock is back in focus after the company agreed a collaboration with Medera to support cardiac gene therapies and human based drug discovery platforms through its global clinical and regulatory infrastructure. See our latest analysis for IQVIA Holdings. The Medera collaboration sits alongside a series of recent updates from IQVIA Holdings, including raised 2026 revenue guidance, a detailed second quarter earnings release and ongoing share repurchases. It also comes after...

Gilead Sciences (GILD) is back in focus after reporting its strongest base business growth in three years, raising full year guidance for HIV sales and core operations despite sizable acquisition related net losses. See our latest analysis for Gilead Sciences. The current Gilead Sciences share price of US$130.86 sits against a year to date share price return of 7.62%, while total shareholder return over five years is 121.58%. That mix of modest recent share price movement and strong long term...

Uber Technologies (UBER) is back under the microscope after its second quarter earnings on 5 August 2026, which combined solid reported profits and gross bookings with a cautious outlook that weighed on investor sentiment. See our latest analysis for Uber Technologies. Uber Technologies' share price has come under pressure in 2026, with a year to date share price return of down 14.95% and a 1 year total shareholder return of down 23.96%, even though the 3 year and 5 year total shareholder...

Hudson Technologies shares closed at US$5.66, down about 9% on the day, as investors reacted quickly to a quarter that looked softer on the surface. Q2 2026 net income came in at US$4.9m on US$78.3m of revenue, with gross margin squeezed to 26% as hydrofluorocarbon pricing stayed weak. Short term traders focused on that margin pressure and the earnings step down from last year. Longer term holders will be weighing that hit against a clean balance sheet with US$26m of cash and no debt, as well...

Amtech Systems came into this earnings print with the stock under pressure, down about 30% over the past three months and off 16% over the past month, and the slide accelerated today with a 7% drop to US$14.95. The headline from the quarter is very different to that price action. Revenue reached US$22.4m with roughly 50% gross margins and about US$3.3m of adjusted EBITDA, supported by strong demand for thermal processing equipment tied to artificial intelligence infrastructure. Is Amtech...

Leadership reshuffle at Steel Dynamics and what it could mean for the stock Steel Dynamics (STLD) has announced a broad leadership reshuffle effective January 1, 2027. As part of the changes, Theresa E. Wagler will become Chief Executive Officer and President, and Mark D. Millett will move to the role of Executive Chairman. See our latest analysis for Steel Dynamics. Against the backdrop of this planned leadership transition, Steel Dynamics’ recent share price momentum has been strong, with a...

In early August 2026, V2X, Inc. reported higher second-quarter sales and earnings, raised its 2026 revenue guidance to US$4,875 million–US$5,025 million, and disclosed new U.S. defense awards, including a US$500 million-ceiling C-12 support contract and an US$87 million SUU-79 pylon sustainment deal running through 2030. Beyond the near-term revenue uplift, these multi-year, fixed-price contracts and the company’s stated focus on margin-accretive M&A highlight how V2X is seeking more...

Eagle Bancorp Montana stock barely flinched after earnings, ticking up just 1.1% to US$23.94. The headline story instead sits on the income statement. The bank posted Q2 basic earnings per share of US$0.47 on revenue of US$23.8m, which keeps profit generation in focus rather than share price moves. For a regional lender often viewed as a quiet compounder, the more notable signal comes from profitability quality. Net interest margin stood at 4.15%, and recent improvements in non performing...

The market rushed back into Tronox Holdings, sending the stock up 18.8% to US$6.95, even though the headline story is still about losses, not profits. This titanium dioxide producer is often pitched as a cheap recovery play, with a P/S around 0.4x and a dividend on the table. Today's Q2 report put that thesis under the microscope. Revenue came in at US$868 million while the company reported another net loss. The gap between a bargain valuation and a balance sheet carrying ongoing losses is...

With inflation still running above the Fed’s 2% target and some officials openly talking about more rate hikes, rate sensitive stocks can feel like a moving target. Essential consumer goods can look relatively steady when borrowing costs rise and growth stories lose their shine. This article walks through three consumer staples stocks exposed to this backdrop, and explains how the same news can create both opportunity and risk for your portfolio. The stocks below are just a sample, and the...

RGC Resources stock inched up about 1.1% to US$21.94 after its Q3 numbers, which is a calm move for what appears to be a clear margin story. Net profit for the quarter was roughly US$0.6m on revenue of about US$17.1m, a far thinner result than the winter heavy Q2 that still anchors the trailing figures investors watch. The market seems to be treating this as just another seasonal dip for a regulated gas utility. The key question is whether this softer quarter hints at a slow squeeze on...